252 related articles for article (PubMed ID: 14578862)
21. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
[TBL] [Abstract][Full Text] [Related]
22. [Prevention of postoperative recurrence after hepatic resection for metastatic colorectal cancer by adjuvant locoregional chemotherapy].
Endo Y; Tani T; Kawaguchi A; Eguchi Y; Sano H; Kurumi Y; Hanasawa K; Ishibashi H; Terata N; Shibata J
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1535-7. PubMed ID: 8396906
[TBL] [Abstract][Full Text] [Related]
23. [Postoperative arterial infusion chemotherapy for hepatocellular carcinoma].
Itamoto T; Asahara T; Okamoto Y; Nakahara H; Katayama K; Nomura S; Marubayashi S; Yahata H; Fukuda Y; Dohi K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1493-6. PubMed ID: 1326915
[TBL] [Abstract][Full Text] [Related]
24. [Prevention of postoperative recurrence of hepatocellular carcinoma by adjuvant locoregional chemotherapy].
Izumi R; Shimizu K; Kiriyama M; Ii T; Iwasa K; Iyobe T; Masutani H; Yagi M; Miyazaki I; Matsui O
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1497-500. PubMed ID: 1326916
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic chemolipiodolization for postoperative hepatoma patients.
Shimoda M; Bando T; Nagata T; Shirosaki I; Sakamoto T; Tsukada K
Hepatogastroenterology; 2001; 48(38):493-7. PubMed ID: 11379340
[TBL] [Abstract][Full Text] [Related]
26. Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis.
Ueno S; Tanabe G; Yoshida A; Yoshidome S; Takao S; Aikou T
Cancer; 1999 Jul; 86(2):248-54. PubMed ID: 10421260
[TBL] [Abstract][Full Text] [Related]
27. Postoperative adjuvant arterial infusion chemotherapy for patients with hepatocellular carcinoma.
Nakashima K; Kitano S; Kim YI; Aramaki M; Kawano K
Hepatogastroenterology; 1996; 43(12):1410-4. PubMed ID: 8975940
[TBL] [Abstract][Full Text] [Related]
28. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
29. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
[TBL] [Abstract][Full Text] [Related]
30. [The effect of hepatic arterial infusion chemotherapy on the prognosis after hepatectomy for hepatocellular carcinoma].
Takagi K; Koyama T; Hasegawa M; Manabe K
Gan To Kagaku Ryoho; 1998 Mar; 25(4):597-600. PubMed ID: 9530370
[TBL] [Abstract][Full Text] [Related]
31. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.
Maluccio M; Covey AM; Gandhi R; Gonen M; Getrajdman GI; Brody LA; Fong Y; Jarnagin W; D'Angelica M; Blumgart L; DeMatteo R; Brown KT
J Vasc Interv Radiol; 2005 Jul; 16(7):955-61. PubMed ID: 16002503
[TBL] [Abstract][Full Text] [Related]
32. Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma.
Uenishi T; Nishiguchi S; Tanaka S; Yamamoto T; Takemura S; Kubo S
J Surg Oncol; 2008 Oct; 98(5):358-62. PubMed ID: 18646001
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?
Tabone M; Vigano L; Laudi C; Ferrero A; Pellerito R; Capussotti L
Hepatology; 2005 Jun; 41(6):1433; author reply 1433-4. PubMed ID: 15834934
[No Abstract] [Full Text] [Related]
34. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
[TBL] [Abstract][Full Text] [Related]
35. Comparative survival analysis of adjuvant therapy with iodine-131-labeled lipiodol to hepatic resection of primary hepatocellular carcinoma: a meta-analysis.
Gong L; Shi L; Sun J; Yuan WS; Chen JF; Liu P; Gong F; Dong JH
Nucl Med Commun; 2014 May; 35(5):484-92. PubMed ID: 24492679
[TBL] [Abstract][Full Text] [Related]
36. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.
Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW
Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271
[TBL] [Abstract][Full Text] [Related]
37. Multimodality management of hepatocellular carcinoma larger than 10 cm.
Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
[TBL] [Abstract][Full Text] [Related]
38. Postoperative adjuvant chemotherapy after radical hepatic resection for hepatocellular carcinoma (HCC).
Kohno H; Nagasue N; Hayashi T; Yamanoi A; Uchida M; Ono T; Yukaya H; Kimura N; Nakamura T
Hepatogastroenterology; 1996; 43(12):1405-9. PubMed ID: 8975939
[TBL] [Abstract][Full Text] [Related]
39. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.
Yang LY; Fang F; Ou DP; Wu W; Zeng ZJ; Wu F
Ann Surg; 2009 Jan; 249(1):118-23. PubMed ID: 19106686
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.
Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M
Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
